Addus HomeCare Corporation (NASDAQ:ADUS) Receives $133.22 Average Price Target from Brokerages

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $133.2222.

ADUS has been the subject of several research analyst reports. Truist Financial set a $135.00 price target on Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Barclays dropped their price target on Addus HomeCare from $112.00 to $102.00 and set an “underweight” rating for the company in a research note on Wednesday, March 25th. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Stephens dropped their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP David W. Tucker sold 379 shares of the company’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $39,931.44. Following the completion of the sale, the executive vice president directly owned 10,423 shares in the company, valued at $1,098,167.28. This represents a 3.51% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael D. Wattenbarger sold 300 shares of the company’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $31,608.00. Following the completion of the sale, the executive vice president directly owned 9,444 shares of the company’s stock, valued at $995,019.84. The trade was a 3.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,788 shares of company stock valued at $1,785,633 over the last three months. Insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of ADUS. Royal Bank of Canada boosted its position in shares of Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock worth $682,000 after buying an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares during the period. Jane Street Group LLC boosted its position in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after buying an additional 8,780 shares during the period. Finally, Intech Investment Management LLC boosted its position in shares of Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after buying an additional 4,439 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $94.46 on Tuesday. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The company has a market cap of $1.76 billion, a P/E ratio of 18.13, a P/E/G ratio of 1.31 and a beta of 0.96. Addus HomeCare has a fifty-two week low of $90.89 and a fifty-two week high of $124.43. The firm’s 50 day moving average is $100.43 and its two-hundred day moving average is $108.43.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.